|
1
|
Kondo K: Therapy for thymic epithelial
tumors. Gen Thorac Cardiovasc Surg. 62:468–474. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shimosato Y, Mukai K and Matsuno Y: Tumors
of the mediastinum. AFIP Atlas of Tumor Pathology, Series 4. Armed
Forces Institute of Pathology; Washington, DC: 2010
|
|
3
|
Kondo K and Monden Y: Therapy for thymic
epithelial tumors: A clinical study of 1,320 patients from Japan.
Ann Thorac Surg. 76:878–885. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ahmad U, Yao X, Detterbeck F, Huang J,
Antonicelli A, Filosso PL, Ruffini E, Travis W, Jones DR, Zhan Y,
et al: Thymic carcinoma outcomes and prognosis: Results of an
international analysis. J Thorac Cardiovasc Surg. 149:95–100,
101.e1-101.e2. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Berghmans T, Durieux V, Holbrechts S,
Jungels C, Lafitte JJ, Meert AP, Moretti L, Ocak S, Roelandts M and
Girard N: Systemic treatments for thymoma and thymic carcinoma: A
systematic review. Lung Cancer. 126:25–31. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Scorsetti M, Leo F, Trama A, D'Angelillo
R, Serpico D, Macerelli M, Zucali P, Gatta G and Garassino MC:
Thymoma and thymic carcinomas. Crit Rev Oncol Hematol. 99:332–350.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Krishnan M and Ganti AK: The role of
targeted therapy in thymic carcinoma. J Oncol Pharm Pract.
25:1712–1718. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thomas A, Rajan A, Berman A, Tomita Y,
Brzezniak C, Lee MJ, Lee S, Ling A, Spittler AJ, Carter CA, et al:
Sunitinib in patients with chemotherapy-refractory thymoma and
thymic carcinoma: An open-label phase 2 trial. Lancet Oncol.
16:177–186. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Giaccone G, Kim C, Thompson J, McGuire C,
Kallakury B, Chahine JJ, Manning M, Mogg R, Blumenschein WM, Tan
MT, et al: Pembrolizumab in patients with thymic carcinoma: A
single-arm, single-centre, phase 2 study. Lancet Oncol. 19:347–355.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Thomas A, Lau C, Rajan A, Zhu Y,
Killian JK, Petrini I, Pham T, Morrow B, Zhong X, et al: Mutations
of epigenetic regulatory genes are common in thymic carcinomas. Sci
Rep. 4:73362014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Radovich M, Pickering CR, Felau I, Ha G,
Zhang H, Jo H, Hoadley KA, Anur P, Zhang J, McLellan M, et al
Cancer Genome Atlas Network, : The integrated genomic landscape of
thymic epithelial tumors. Cancer Cell. 33:244–258.e10. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saito M, Fujiwara Y, Asao T, Honda T,
Shimada Y, Kanai Y, Tsuta K, Kono K, Watanabe S, Ohe Y, et al: The
genomic and epigenomic landscape in thymic carcinoma.
Carcinogenesis. 38:1084–1091. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Enkner F, Pichlhöfer B, Zaharie AT, Krunic
M, Holper TM, Janik S, Moser B, Schlangen K, Neudert B, Walter K,
et al: Molecular profiling of thymoma and thymic carcinoma: Genetic
differences and potential novel therapeutic targets. Pathol Oncol
Res. 23:551–564. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Petrini I, Meltzer PS, Kim IK, Lucchi M,
Park KS, Fontanini G, Gao J, Zucali PA, Calabrese F, Favaretto A,
et al: A specific missense mutation in GTF2I occurs at high
frequency in thymic epithelial tumors. Nat Genet. 46:844–849. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hirose Y, Kondo K, Takizawa H, Nagao T,
Nakagawa Y, Fujino H, Toba H, Kenzaki K, Sakiyama S and Tangoku A:
Aberrant methylation of tumour-related genes in thymic epithelial
tumours. Lung Cancer. 64:155–159. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mokhtar M, Kondo K, Namura T, Ali AH,
Fujita Y, Takai C, Takizawa H, Nakagawa Y, Toba H, Kajiura K, et
al: Methylation and expression profiles of MGMT gene in thymic
epithelial tumors. Lung Cancer. 83:279–287. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kajiura K, Takizawa H, Morimoto Y, Masuda
K, Tsuboi M, Kishibuchi R, Wusiman N, Sawada T, Kawakita N, Toba H,
et al: Frequent silencing of RASSF1A by DNA methylation in thymic
neuroendocrine tumours. Lung Cancer. 111:116–123. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kishibuchi R, Kondo K, Soejima S, Tsuboi
M, Kajiura K, Kawakami Y, Kawakita N, Sawada T, Toba H, Yoshida M,
et al: DNA methylation of GHSR, GNG4, HOXD9 and SALL3 is a common
epigenetic alteration in thymic carcinoma. Int J Oncol. 56:315–326.
2020.PubMed/NCBI
|
|
19
|
Erlander MG and Tobin AJ: The structural
and functional heterogeneity of glutamic acid decarboxylase: A
review. Neurochem Res. 16:215–226. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bu DF and Tobin AJ: The exon-intron
organization of the genes (GAD1 and GAD2) encoding two human
glutamate decarboxylases (GAD67 and GAD65) suggests that they
derive from a common ancestral GAD. Genomics. 21:222–228. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yan H, Tang G, Wang H, Hao L, He T, Sun X,
Ting AH, Deng A and Sun S: DNA methylation reactivates GAD1
expression in cancer by preventing CTCF-mediated polycomb
repressive complex 2 recruitment. Oncogene. 35:3995–4008. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kimura R, Kasamatsu A, Koyama T, Fukumoto
C, Kouzu Y, Higo M, Endo-Sakamoto Y, Ogawara K, Shiiba M, Tanzawa
H, et al: Glutamate acid decarboxylase 1 promotes metastasis of
human oral cancer by β-catenin translocation and MMP7 activation.
BMC Cancer:. 13:5552013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee YY, Chao TB, Sheu MJ, Tian YF, Chen
TJ, Lee SW, He HL, Chang IW, Hsing CH, Lin CY, et al: Glutamate
decarboxylase 1 overexpression as a poor prognostic factor in
patients with nasopharyngeal carcinoma. J Cancer. 7:1716–1723.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Maemura K, Yamauchi H, Hayasaki H, Kanbara
K, Tamayama T, Hirata I and Watanabe M: Gamma-amino-butyric acid
immunoreactivity in intramucosal colonic tumors. J Gastroenterol
Hepatol. 18:1089–1094. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Matuszek M, Jesipowicz M and Kleinrok Z:
GABA content and GAD activity in gastric cancer. Med Sci Monit.
7:377–381. 2001.PubMed/NCBI
|
|
26
|
Tsuboi M, Kondo K, Masuda K, Tange S,
Kajiura K, Kohmoto T, Takizawa H, Imoto I and Tangoku A: Prognostic
significance of GAD1 overexpression in patients with resected lung
adenocarcinoma. Cancer Med. 8:4189–4199. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Phillips JE and Corces VG: CTCF: Master
weaver of the genome. Cell. 137:1194–1211. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim TH, Abdullaev ZK, Smith AD, Ching KA,
Loukinov DI, Green RD, Zhang MQ, Lobanenkov VV and Ren B: Analysis
of the vertebrate insulator protein CTCF-binding sites in the human
genome. Cell. 128:1231–1245. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Travis WD, Brambilla E, Burke AP, Marx A
and Nicholson AG: WHO classification of tumours of the lung,
pleura, thymus and heart. World Health Organization Classification
of Tumours. 4th edition. Bosman FT, Jaffe ES, Lakhani SR and Ohgaki
H: IARC Press; Lyon: pp. 183–243. 2015
|
|
30
|
Detterbeck FC, Nicholson AG, Kondo K, Van
Schil P and Moran C: The Masaoka-Koga stage classification for
thymic malignancies: Clarification and definition of terms. J
Thorac Oncol. 6 (Suppl 3):S1710–S1716. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Suster S and Moran CA: Primary thymic
epithelial neoplasms showing combined features of thymoma and
thymic carcinoma. A clinicopathologic study of 22 cases. Am J Surg
Pathol. 20:1469–1480. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Weissferdt A and Moran CA: Thymic
carcinoma, part 1: A clinicopathologic and immunohistochemical
study of 65 cases. Am J Clin Pathol. 138:103–114. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Heckers S, Stone D, Walsh J, Shick J, Koul
P and Benes FM: Differential hippocampal expression of glutamic
acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and
schizophrenia. Arch Gen Psychiatry. 59:521–529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang HS and Akbarian S: GAD1 mRNA
expression and DNA methylation in prefrontal cortex of subjects
with schizophrenia. PLoS One. 2:e8092007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li CM, Kim CE, Margolin AA, Guo M, Zhu J,
Mason JM, Hensle TW, Murty VV, Grundy PE, Fearon ER, et al: CTNNB1
mutations and overexpression of Wnt/β-catenin target genes in
WT1-mutant Wilms' tumors. Am J Pathol. 165:1943–1953. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vodicka P, Krskova L, Odintsov I, Krizova
L, Sedlackova E, Schutzner J and Zamecnik J: Expression of
molecules of the Wnt pathway and of E-cadherin in the
etiopathogenesis of human thymomas. Oncol Lett. 19:2413–2421.
2020.PubMed/NCBI
|
|
37
|
Yoshino I, Kase S, Yano T, Sugio K and
Sugimachi K: Expression status of E-cadherin and α-, β-, and
γ-catenins in thymoma. Ann Thorac Surg. 73:933–937. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pan CC, Ho DM, Chen WY, Chiang H, Fahn HJ
and Wang LS: Expression of E-cadherin and α- and β-catenins in
thymoma. J Pathol. 184:207–211. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Takahashi E, Tateyama H, Akatsu H, Fukai
I, Yamakawa Y, Fujii Y and Eimoto T: Expression of matrix
metalloproteinases 2 and 7 in tumor cells correlates with the World
Health Organization classification subtype and clinical stage of
thymic epithelial tumors. Hum Pathol. 34:1253–1258. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gius D, Cui H, Bradbury CM, Cook J, Smart
DK, Zhao S, Young L, Brandenburg SA, Hu Y, Bisht KS, et al:
Distinct effects on gene expression of chemical and genetic
manipulation of the cancer epigenome revealed by a multimodality
approach. Cancer Cell. 6:361–371. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lai AY, Fatemi M, Dhasarathy A, Malone C,
Sobol SE, Geigerman C, Jaye DL, Mav D, Shah R, Li L, et al: DNA
methylation prevents CTCF-mediated silencing of the oncogene BCL6
in B cell lymphomas. J Exp Med. 207:1939–1950. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Renaud S, Loukinov D, Abdullaev Z,
Guilleret I, Bosman FT, Lobanenkov V and Benhattar J: Dual role of
DNA methylation inside and outside of CTCF-binding regions in the
transcriptional regulation of the telomerase hTERT gene. Nucleic
Acids Res. 35:1245–1256. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ha M, Ng DW, Li WH and Chen ZJ:
Coordinated histone modifications are associated with gene
expression variation within and between species. Genome Res.
21:590–598. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Schuettengruber B, Chourrout D, Vervoort
M, Leblanc B and Cavalli G: Genome regulation by polycomb and
trithorax proteins. Cell. 128:735–745. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bell AC and Felsenfeld G: Methylation of a
CTCF-dependent boundary controls imprinted expression of the Igf2
gene. Nature. 405:482–485. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hark AT, Schoenherr CJ, Katz DJ, Ingram
RS, Levorse JM and Tilghman SM: CTCF mediates methylation-sensitive
enhancer-blocking activity at the H19/Igf2 locus. Nature.
405:486–489. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
de Jong WK, Blaauwgeers JLG, Schaapveld M,
Timens W, Klinkenberg TJ and Groen HJ: Thymic epithelial tumours: A
population-based study of the incidence, diagnostic procedures and
therapy. Eur J Cancer. 44:123–130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gadalla SM, Rajan A, Pfeiffer R,
Kristinsson SY, Björkholm M, Landgren O and Giaccone G: A
population-based assessment of mortality and morbidity patterns
among patients with thymoma. Int J Cancer. 128:2688–2694. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mariusdottir E, Nikulasson S, Bjornsson J
and Gudbjartsson T: Thymic epithelial tumours: A population-based
study. APMIS. 118:927–933. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhao Y, Zhao H, Hu D, Fan L, Shi J and
Fang W: Surgical treatment and prognosis of thymic squamous cell
carcinoma: A retrospective analysis of 105 cases. Ann Thorac Surg.
96:1019–1024. 2013. View Article : Google Scholar : PubMed/NCBI
|
